| Product Code: ETC071144 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Thailand Infectious Disease Biomarker Testing Market was estimated at USD 103 Million in 2025 and is projected to reach USD 118 Million by 2032, growing at a CAGR of 2.0% from 2026 to 2032. This growth is primarily propelled by the rising prevalence of infectious diseases within the region, necessitating early and accurate diagnostics to inform treatment strategies. Additionally, innovations in diagnostic technology and robust government support for healthcare infrastructure further underline the potential for sustained market expansion.
The Thailand Infectious Disease Biomarker Testing market has shown a notable recovery since its decline of 3.2% in 2021. This shift is attributed to increased healthcare investments and a rising public awareness of infectious diseases, leading to a growth of 2.6% in 2022 and a further acceleration to 3.3% in 2023. As regulatory frameworks become more supportive and technology evolves, the market is expected to see steady growth, with projections of 3.6% in 2025. However, minor fluctuations, such as the anticipated 2.4% growth in 2027, may stem from temporary market adjustments and competition. By 2031, the market is expected to reach a healthy growth rate of 3.3%, driven by advancements in diagnostic technology and sustainable healthcare practices.
This graph highlights how the Thailand Infectious Disease Biomarker Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.2% | Increasing smart city development projects |
| 2022 | 2.6% | Rapid growth in telecom and data center sectors |
| 2023 | 3.3% | Increasing adoption of advanced technologies |
| 2024 | 2.6% | Expansion of transportation and logistics networks |
| 2025 | 3.6% | Expansion of manufacturing activities |
| 2026 | 2.9% | Rising electricity demand across industries |
| 2027 | 2.4% | Increasing smart city development projects |
| 2028 | 3.0% | Increasing adoption of advanced technologies |
| 2029 | 2.7% | Rising electricity demand across industries |
| 2030 | 2.7% | Expansion of commercial construction activities |
| 2031 | 3.3% | Increasing smart city development projects |
| 2032 | 3.0% | Expansion of manufacturing activities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In Thailand, the demand for infectious disease biomarker testing is underscored by a pressing need for rapid and precise diagnostic solutions amid challenges posed by endemic diseases like dengue fever and tuberculosis. This sector's growth is fundamentally linked to advancements in testing methodologies, which empower healthcare providers to make informed decisions about patient care swiftly.
Moreover, an increasing public awareness of the importance of early disease detection is shaping the landscape of biomarker testing. As healthcare facilities across Thailand integrate new technologies, there is a significant push towards personalized medicine, amplifying the relevance of biomarker testing in managing infectious diseases efficiently.
Despite the promising outlook, the Thailand infectious disease biomarker testing market faces notable constraints. Continuous research and development are paramount, as the emergence of new pathogens demands innovative testing solutions that can keep pace with evolving disease landscapes. Moreover, accessibility remains a challenge, particularly in remote areas where healthcare resources are scarce. Ensuring affordability and reliability of biomarker tests in these regions will require concerted efforts among healthcare stakeholders, including public health entities and private diagnostic firms.
Current trends in the Thailand infectious disease biomarker testing market reveal a shift towards molecular and rapid testing technologies. Point-of-care testing is gaining traction due to its efficiency and the immediacy it brings to disease diagnosis and management. Additionally, the integration of artificial intelligence in diagnostics is emerging as a trend, optimizing test interpretation and enhancing accuracy. As the healthcare sector evolves, these technological advancements are poised to reshape patient management strategies significantly.
The market presents ample opportunities for growth, particularly in the development of innovative biomarker tests tailored to emerging infectious diseases. Investment in local laboratories and partnerships with research institutions can enhance the testing landscape significantly. Additionally, increasing collaboration between public and private sectors can foster the creation of cost-effective solutions, extending the reach of biomarker testing to underserved populations and ensuring comprehensive disease management.
The Thai government has actively promoted initiatives to bolster healthcare infrastructure, including disease surveillance programs and investments in diagnostic technologies. Public spending has focused on enhancing laboratory capabilities and increasing access to testing services across urban and rural settings. These initiatives aim not only to improve the overall health landscape but also to ensure timely and effective responses to infectious disease outbreaks.
Looking ahead to 2026-2032, the Thailand infectious disease biomarker testing market is positioned for steady growth. Continuous advancements in diagnostic technologies, coupled with a strategic focus on personalized medicine, will likely influence market dynamics positively. The experience gained from managing the Covid-19 pandemic is anticipated to fortify the country’s healthcare infrastructure, emphasizing the critical role of rapid and accurate biomarker testing in future infectious disease control efforts.
In recent months, the Thailand infectious disease biomarker testing market has witnessed several notable developments. The introduction of novel testing solutions aimed at improving the speed and accuracy of diagnostics has gained momentum. There has been increased collaboration between healthcare providers and technology firms to enhance the capabilities of existing testing frameworks. Furthermore, public health campaigns focusing on disease awareness have highlighted the importance of early detection and timely intervention, thereby driving demand for biomarker testing.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Infectious Disease Biomarker Testing Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Thailand Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Thailand Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Thailand |
4.2.2 Growing awareness about the importance of early disease detection |
4.2.3 Technological advancements in biomarker testing leading to more accurate and efficient diagnosis |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with biomarker testing |
4.3.3 Stringent regulations and approval processes for new biomarker testing technologies |
5 Thailand Infectious Disease Biomarker Testing Market Trends |
6 Thailand Infectious Disease Biomarker Testing Market, By Types |
6.1 Thailand Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 Thailand Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 Thailand Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 Thailand Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Thailand Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Thailand Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Thailand Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Thailand Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Percentage increase in the adoption of biomarker testing technologies in Thailand |
8.2 Number of research and development initiatives focused on infectious disease biomarker testing |
8.3 Rate of government funding allocated to support biomarker testing initiatives for infectious diseases |
9 Thailand Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Thailand Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Thailand Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 Thailand Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Thailand Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Thailand Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2025 |
10.2 Thailand Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here